Korean Diabetes J.  2010 Jun;34(3):154-156. 10.4093/kdj.2010.34.3.154.

Early Insulin Secretory Dysfunction in Korean Prediabetic Subjects: Should We Change the Criteria for "Prediabetes?"

• Kim CH

• KMID: 2222370
• DOI: http://doi.org/10.4093/kdj.2010.34.3.154

Abstract

No abstract available.

MeSH Terms

Insulin
Insulin

Reference

1. Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, Groop LC. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes. 2000. 49:975–980.

2. Carnevale Schianca GP, Rossi A, Sainaghi PP, Maduli E, Bartoli E. The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care. 2003. 26:1333–1337.

3. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006. 55:1430–1435.

4. Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care. 2006. 29:1909–1914.

5. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988. 37:667–687.

6. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 1992. 15:318–368.

7. Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 1999. 48:2197–2203.

8. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab. 2005. 90:493–500.

9. Stancakova A, Javorsky M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes. 2009. 58:1212–1221.

10. Utzschneider KM, Prigeon RL, Carr DB, Hull RL, Tong J, Shofer JB, Retzlaff BM, Knopp RH, Kahn SE. Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. Diabetes Care. 2006. 29:356–362.

11. Abdul-Ghani MA, Matsuda M, Jani R, Jenkinson CP, Coletta DK, Kaku K, DeFronzo RA. The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance. Am J Physiol Endocrinol Metab. 2008. 295:E401–E406.

12. Faerch K, Vaag A, Holst JJ, Hansen T, Jorgensen T, Borch-Johnsen K. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care. 2009. 32:439–444.

13. Kim YI, Choi CS, Kim SW, Kim HK, Kim CH, Park JY, Hong SK, Lee KU. Changes in serum true insulin and C-peptide levels during oral glucose tolerance test in Koreans with glucose intolerance. J Korean Diabetes Assoc. 1998. 22:192–198.

14. Kim DJ, Lee MS, Kim KW, Lee MK. Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism. 2001. 50:590–593.

15. Kim J, Choi S, Kong B, Oh Y, Shinn S. Insulin secretion and sensitivity during oral glucose tolerance test in Korean lean elderly women. J Korean Med Sci. 2001. 16:592–597.

16. Rhee SY, Chon S, Oh S, Kim SW, Kim JW, Kim YS, Woo JT. Insulin secretion and insulin resistance in newly diagnosed, drug naive prediabetes and type 2 diabetes patients with/without metabolic syndrome. Diabetes Res Clin Pract. 2007. 76:397–403.

17. Rhee SY, Woo JT, Chon S, Hwang YC, Jeong IK, Oh SJ, Ahn KJ, Chung HY, Kim SW, Kim JW, Kim YS. The change of early phase insulin secretion in newly diagnosed, drug naive Korean prediabetes subjects. Korean Diabetes J. 2010. 34:157–165.

18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010. 33:Suppl 1. S62–S69.

19. Singh R, Pearson E, Avery PJ, McCarthy MI, Levy JC, Hitman GA, Sampson M, Walker M, Hattersley AT. Reduced beta cell function in offspring of mothers with young-onset type 2 diabetes. Diabetologia. 2006. 49:1876–1880.

20. Stadler M, Pacini G, Petrie J, Luger A, Anderwald C. Beta cell (dys)function in non-diabetic offspring of diabetic patients. Diabetologia. 2009. 52:2435–2444.

21. Chang SA, Son HY, Cha BY, Moon SD, Song KH, Yoo SJ, Yoon KH, Kang MI, Lee KW, Kang SK. Fasting serum insulin levels in relation to age and body mass index and serum glucose level in healthy subjects in Korea. J Korean Diabetes Assoc. 1997. 21:433–443.